252 related articles for article (PubMed ID: 11181357)
1. Activities of linezolid against rapidly growing mycobacteria.
Wallace RJ; Brown-Elliott BA; Ward SC; Crist CJ; Mann LB; Wilson RW
Antimicrob Agents Chemother; 2001 Mar; 45(3):764-7. PubMed ID: 11181357
[TBL] [Abstract][Full Text] [Related]
2. Activities of Linezolid against nontuberculous mycobacteria.
Cavusoglu C; Soyler I; Akinci P
New Microbiol; 2007 Oct; 30(4):411-4. PubMed ID: 18080676
[TBL] [Abstract][Full Text] [Related]
3. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.
Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
Yang SC; Hsueh PR; Lai HC; Teng LJ; Huang LM; Chen JM; Wang SK; Shie DC; Ho SW; Luh KT
Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
[TBL] [Abstract][Full Text] [Related]
6. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
[TBL] [Abstract][Full Text] [Related]
7. Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth.
Cremades R; Santos A; Rodríguez JC; García-Pachón E; Ruiz M; Escribano I; Royo G
Chemotherapy; 2009; 55(2):114-8. PubMed ID: 19155619
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of Linezolid on clinical strains of Mycobacterium tuberculosis and other mycobacteria.
Molicotti P; Ortu S; Bua A; Cannas S; Sechi LA; Zanetti S
New Microbiol; 2006 Oct; 29(4):275-80. PubMed ID: 17201094
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
Stein GE; Schooley SL; Peloquin CA; Kak V; Havlichek DH; Citron DM; Tyrrell KL; Goldstein EJ
Ann Pharmacother; 2005 Mar; 39(3):427-32. PubMed ID: 15701775
[TBL] [Abstract][Full Text] [Related]
11. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
Shen GH; Wu BD; Hu ST; Lin CF; Wu KM; Chen JH
Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
[TBL] [Abstract][Full Text] [Related]
12. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
Abshire R; Cockrum P; Crider J; Schlech B
Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
[TBL] [Abstract][Full Text] [Related]
13. In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.
Shen GH; Wu BD; Wu KM; Chen JH
Antimicrob Agents Chemother; 2007 May; 51(5):1849-51. PubMed ID: 17353252
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Efficacy of Novel Oxazolidinone Analogues against Nontuberculous Mycobacteria In Vitro.
Zhao W; Jiang Y; Bao P; Li Y; Tang L; Zhou Y; Zhao Y
Jpn J Infect Dis; 2015; 68(6):520-2. PubMed ID: 25971324
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria].
Ruiz-Aragón J; García-Agudo L; Flores S; Rodríguez MJ; Marín P; García-Martos P
Rev Esp Quimioter; 2007 Dec; 20(4):429-32. PubMed ID: 18563216
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of linezolid against multiple Nocardia species.
Brown-Elliott BA; Ward SC; Crist CJ; Mann LB; Wilson RW; Wallace RJ
Antimicrob Agents Chemother; 2001 Apr; 45(4):1295-7. PubMed ID: 11257051
[TBL] [Abstract][Full Text] [Related]
17. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
Erturan Z; Uzun M
Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
[TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
Hoel T; Casals JB; Eng J
APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.
Guna R; Muñoz C; Domínguez V; García-García A; Gálvez J; de Julián-Ortiz JV; Borrás R
J Antimicrob Chemother; 2005 Jun; 55(6):950-3. PubMed ID: 15824090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
